PRE logo

Prenetics Global Limited (PRE)

Profile

Full Name

Prenetics Global Limited

Ticker Symbol

PRE

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

Hong Kong

IPO

July 16, 2021

Indexes

Not included

Website

http://www.prenetics.com

Employees

285

Key Details

Price

$10.05(+0.18%)

Market cap

$130.99M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$30.62M(+40.83% YoY)

Annual EPS

-$3.71(+33.51% YoY)

PE ratio

-

Next earnings date

Jun 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.05
    PRE price is $10.05

    30-Day Relative Volume

    0.70
    PRE 30-day relative volume is 0.70

    Price Performance

    Price Most recent change

    +0.18%
    PRE price was up +0.18% on May 28, 2025

    Price YTD change

    +73.28%
    PRE price is up +73.28% since January 1st

    Price 1-year change

    +74.48%
    PRE price is up +74.48% year-on-year

    Price 3-year change

    -86.94%
    PRE price is down -86.94% over the past 3 years

    Price Range

    Price All-time high

    $131.25
    PRE price is currently -92.34% below its historical high of $131.25

    Price 3-year low

    $2.85
    PRE price is currently +252.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $130.99M
    PRE market capitalization is $130.99 million

    Market cap 3-year change

    -76.99%
    PRE market capitalization is down -76.99% over the past 3 years

    Market cap All-time high

    $848.99M
    PRE market capitalization is currently -84.57% below its historical high of $848.99 million

    Market cap sector rank

    49.47%
    PRE market capitalization is higher than 49.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +6.69%
    PRE shares outstanding is up +6.69% year-on-year

    Shares Outstanding 3-Year Change

    +76.17%
    PRE shares outstanding is up +76.17% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.33
    PRE beta is -0.33

    200-day SMA

    $5.02
    PRE price is currently +100.20% above its 200-day simple moving average

    50-day SMA

    $5.16
    PRE price is currently +94.68% above its 50-day simple moving average

    RSI

    78.59
    PRE 14-day relative strength index is 78.59

    Volume

    0.70
    PRE 30-day relative volume is 0.70

    ATR

    $0.86
    PRE average true range is $0.86

    10-day Historical Volatility

    202.18%
    PRE 10-day historical volatility is 202.18%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $30.62M
    PRE annual revenue is $30.62 million

    Revenue Analysts estimate

    $79.10M
    PRE annual revenue is currently -61.29% lower than the consensus analysts' forecast

    Revenue 1-year change

    +40.83%
    PRE annual revenue is up +40.83% year-on-year

    Revenue Sector rank

    39.16%
    PRE annual revenue is higher than 39.16% of companies in Healthcare sector

    EPS

    EPS

    -$3.71
    PRE annual earnings per share is -$3.71

    EPS Analysts estimate

    -
    PRE annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +33.51%
    PRE annual earnings per share is up +33.51% year-on-year

    EPS Sector rank

    23.74%
    PRE annual earnings per share is higher than 23.74% of companies in Healthcare sector

    Profit

    Gross profit

    $15.40M
    PRE annual gross profit is $15.40 million

    Gross margin

    50.29%
    PRE annual gross profit margin is 50.29%

    Operating profit

    -$50.89M
    PRE annual operating income is -$50.89 million

    Operating margin

    -166.19%
    PRE annual operating profit margin is -166.19%

    Net income

    -$46.30M
    PRE annual net profit is -$46.30 million

    Net margin

    -151.22%
    PRE annual net profit margin is -151.22%

    Expenses

    Total expenses

    $81.51M
    PRE annual total expenses is $81.51 million

    Operating expenses

    $66.29M
    PRE annual total operating expenses is $66.29 million

    Cost of goods sold

    $15.22M
    PRE annual cost of goods sold is $15.22 million

    Selling, general & administrative expenses

    $55.37M
    PRE annual SGA is $55.37 million

    Depreciation and amortization

    $5.93M
    PRE annual depreciation & amortization is $5.93 million

    Interest expense

    $203.00K
    PRE annual interest expense is $203.00 thousand

    Income tax

    -$7.87M
    PRE annual income tax is -$7.87 million

    EBIT & EBITDA

    EBIT

    -$57.50M
    PRE annual earnings before interest & taxes is -$57.50 million

    EBITDA

    -$51.57M
    PRE annual EBITDA is -$51.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $213.57M
    PRE annual total assets is $213.57 million

    Non current assets

    $127.43M
    PRE annual long term assets is $127.43 million

    Current assets

    $86.15M
    PRE annual total current assets is $86.15 million

    Cash and cash equivalents

    $52.25M
    PRE annual cash & cash equivalents is $52.25 million

    Accounts receivable

    $5.24M
    PRE annual accounts receivable is $5.24 million

    Inventory

    $6.57M
    PRE annual inventory is $6.57 million

    Liabilities

    Total liabilities

    $42.23M
    PRE annual total liabilities is $42.23 million

    Long term liabilities

    $5.68M
    PRE annual total long term liabilities is $5.68 million

    Current liabilities

    $36.55M
    PRE annual total current liabilities is $36.55 million

    Accounts payable

    $3.67M
    PRE annual accounts payable is $3.67 million

    Debt

    Total debt

    $5.77M
    PRE annual total debt is $5.77 million

    Total debt 1-year change

    +143.65%
    PRE annual total debt is up +143.65% year-on-year

    Long term debt

    $3.01M
    PRE annual long term debt is $3.01 million

    Short term debt

    $2.76M
    PRE annual short term debt is $2.76 million

    Equity & Capital

    Shareholders equity

    $170.39M
    PRE annual stockholders equity is $170.39 million

    Book value

    $170.39M
    PRE annual book value is $170.39 million

    Retained earnings

    -$517.07M
    PRE annual retained earnings is -$517.07 million

    Working capital

    $49.60M
    PRE annual working capital is $49.60 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$28.87M
    PRE annual cash flow from operations is -$28.87 million

    Cash from operations 1-year change

    -109.76%
    PRE annual cash flow from operations is down -109.76% year-on-year

    Cash from investing

    $38.54M
    PRE annual cash flow from investing activities is $38.54 million

    Cash from investing 1-year change

    +146.46%
    PRE annual cash flow from investing activities is up +146.46% year-on-year

    Cash from financing

    -$3.34M
    PRE annual cash flow from financing activities is -$3.34 million

    Cash from financing 1-year change

    +28.93%
    PRE annual cash flow from financing activities is up +28.93% year-on-year

    CAPEX

    CAPEX

    $1.06M
    PRE annual capital expenditures is $1.06 million

    CAPEX 1-year change

    +16.78%
    PRE annual capital expenditures is up +16.78% year-on-year

    Free Cash Flow

    Free cash flow

    -$29.94M
    PRE annual free cash flow is -$29.94 million

    Free cash flow 1-year change

    -103.99%
    PRE annual free cash flow is down -103.99% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    50.29%
    PRE annual gross profit margin is 50.29%

    Operating margin

    -166.19%
    PRE annual operating profit margin is -166.19%

    Net margin

    -151.22%
    PRE annual net profit margin is -151.22%

    ROA & ROE

    ROA

    -19.80%
    PRE annual return on assets is -19.80%

    ROE

    -24.27%
    PRE annual return on equity is -24.27%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    PRE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    PRE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.77
    PRE price to book ratio is 0.77

    PB ratio Sector rank

    35.44%
    PRE price to book ratio is higher than 35.44% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.28
    PRE price to sales ratio is 4.28

    PS ratio Sector rank

    60.63%
    PRE price to sales ratio is higher than 60.63% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $84.51M
    PRE enterprise value is $84.51 million

    Enterprise value Sector rank

    45.66%
    PRE enterprise value is higher than 45.66% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.47
    PRE EV/EBITDA is -1.47

    EV/EBITDA Sector rank

    40.71%
    PRE EV/EBITDA is higher than 40.71% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.36
    PRE annual current ratio is 2.36

    Quick ratio

    2.18
    PRE annual quick ratio is 2.18

    Leverage

    Debt to equity

    0.00
    PRE annual debt to equity ratio is 0.00

    Interest coverage ratio

    -283.25
    PRE annual interest coverage ratio is -283.25

    Risk & Stability

    Piotroski F-Score

    -
    PRE piotroski f-score value is unknown

    Altman Z-Score

    -1.99
    PRE altman z-score is -1.99

    Analyst ratings

    Recent major analysts updates

    Jan 16, 25 Cantor Fitzgerald
    Overweight
    Dec 4, 24 Cantor Fitzgerald
    Overweight
    Apr 4, 24 Cantor Fitzgerald
    Overweight
    Sep 26, 23 Cantor Fitzgerald
    Overweight
    Sep 19, 23 Cantor Fitzgerald
    Overweight
    Aug 22, 23 Cantor Fitzgerald
    Overweight
    Jan 18, 23 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with PRE included

    Growing Shares Outstanding
    Hong Kong stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Prenetics Global Limited?
    • Does Prenetics Global Limited pay dividends?
    • What sector is Prenetics Global Limited in?
    • What industry is Prenetics Global Limited in?
    • What country is Prenetics Global Limited based in?
    • When did Prenetics Global Limited go public?
    • Is Prenetics Global Limited in the S&P 500?
    • Is Prenetics Global Limited in the NASDAQ 100?
    • Is Prenetics Global Limited in the Dow Jones?
    • When was Prenetics Global Limited's last earnings report?
    • When does Prenetics Global Limited report earnings?
    • Should I buy Prenetics Global Limited stock now?

    What is the ticker symbol for Prenetics Global Limited?

    The ticker symbol for Prenetics Global Limited is NASDAQ:PRE

    Does Prenetics Global Limited pay dividends?

    No, Prenetics Global Limited does not pay dividends

    What sector is Prenetics Global Limited in?

    Prenetics Global Limited is in the Healthcare sector

    What industry is Prenetics Global Limited in?

    Prenetics Global Limited is in the Diagnostics & Research industry

    What country is Prenetics Global Limited based in?

    Prenetics Global Limited is headquartered in Hong Kong

    When did Prenetics Global Limited go public?

    Prenetics Global Limited's initial public offering (IPO) was on July 16, 2021

    Is Prenetics Global Limited in the S&P 500?

    No, Prenetics Global Limited is not included in the S&P 500 index

    Is Prenetics Global Limited in the NASDAQ 100?

    No, Prenetics Global Limited is not included in the NASDAQ 100 index

    Is Prenetics Global Limited in the Dow Jones?

    No, Prenetics Global Limited is not included in the Dow Jones index

    When was Prenetics Global Limited's last earnings report?

    Prenetics Global Limited's most recent earnings report was on Mar 5, 2025

    When does Prenetics Global Limited report earnings?

    The next expected earnings date for Prenetics Global Limited is Jun 18, 2025

    Should I buy Prenetics Global Limited stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page